Sign in

Abortion pill misuse flagged as Delhi chemists caught selling MTP kits illegally

Between Sept 5–7, DDCD inspectors visited 157 chemists; 41 sold MTP kits illegally, triggering strict action under the Drugs and Cosmetics Act.

Published on: Sep 10, 2025, 05:12:06 IST
Share
Share via
  • facebook
  • twitter
  • linkedin
  • whatsapp
Copy link
  • copy link

Officials from the Delhi Drugs Control Department (DDCD) fanned out across the city on three-day undercover mission in the past week where they visited retail chemists selling medical termination of pregnancy (MTP) kits without prescriptions. Their findings were alarming – more than a quarter of chemists inspected sold the kits illegally.

Crackdown follows rising complaints from gynaecologists of young women arriving in hospitals with severe complications from unsupervised abortion pills. (Getty Images/iStockphoto)
Crackdown follows rising complaints from gynaecologists of young women arriving in hospitals with severe complications from unsupervised abortion pills. (Getty Images/iStockphoto)

Between September 5 and 7, an undercover team posed as customers and visited pharmacies across the city, including areas such as Badarpur, Jasola, Kalkaji, Pul Pehladpur, Laxmi Nagar, Ghonda, Moujpur, Rohini, Pitampura, Shalimar Bagh, Uttam Nagar, Budh Vihar, Rithala, Madipur, Hari Nagar, and Nangloi. Out of 157 chemists checked – including those located close to hospitals and nursing homes – 41 dispensed the kits without demanding a prescription from a registered medical practitioner, according to two DDCD officials aware of the findings of the operation.

A female drug inspector involved in the operation described the method. “We created two scenarios. Male inspectors said they were buying the kit for their partners, while female inspectors posed as customers themselves. In both cases, decoy members approached first, while the rest of the team stayed on standby outside. As soon as the chemist sold the kit, the team moved in and took action.”

Strict proceedings have now been initiated against violators under the Drugs and Cosmetics Act, 1940, and the Drugs Rules, 1945, the officials cited above said.

An MTP kit, which contains two medicines, Mifepristone and Misoprostol, is used to terminate early pregnancies up to seven weeks.

By law, the drugs must only be prescribed and supervised by a qualified doctor under the Medical Termination of Pregnancy Act, 1971.

As per the act, and regulations provided on the website of the ministry of family welfare, “In the case of termination of early pregnancy up to 7 weeks using RU-486 with Misoprostol, the same may be prescribed by a Registered Medical Practitioner (RMP) as defined under clause (d) of section 2 of the Act and Section 4 of MTP Rules, at his clinic, provided such a Registered Medical Practitioner has access to a place approved under Section 4 of the MTP Act, 1971 read with MTP Amendment Act, 2002 and Rules 5 of the MTP Rules.”

Doctors are required to rule out conditions such as ectopic pregnancies, ensure the gestational age is within permissible limits, and provide follow-up care.

The crackdown, officials said, followed a wave of complaints from gynaecologists who reported a growing number of young women arriving in hospitals with severe complications after taking abortion pills unsupervised. “We were getting inputs from neighbouring states as well, including Haryana, about the rising illegal sale of MTP kits and its impact on girls’ health,” said one of the officials. “We felt a proactive inspection was necessary.”

The department has also issued an appeal to citizens: “Do not purchase or use MTP kits without consulting a registered medical practitioner. Unsafe use can have serious health implications.”

Doctors raise alarm

Abortion pill misuse flagged as Delhi chemists caught selling MTP kits illegally
Abortion pill misuse flagged as Delhi chemists caught selling MTP kits illegally

Doctors said the risks of unsupervised use are often underestimated.

Dr Neelam Suri, senior consultant, obstetrics and gynaecology at Indraprastha Apollo Hospitals, said: “Women must realise the necessity of medical supervision. Stringent measures are essential to prevent unsafe practices.”

Dr Rahul Manchanda, endoscopic gynaecology specialist at PSRI Hospital, added that secrecy and lack of awareness compound the danger. “Many women, and sometimes even minor girls, resort to these pills without counselling or medical support. These are not over-the-counter medicines. Their safe use depends on multiple factors such as the stage of pregnancy, medical history, and overall health. A doctor is needed to rule out conditions like ectopic pregnancy, to guide follow-up care, and to handle complications if they arise. Raising awareness, enforcing rules, and encouraging open conversations around reproductive health are urgent priorities.”

Echoing this, Dr Shaily Sharma, gynaecologist at Cloudnine Hospital, said that many gynaecologists have been witnessing a worrying trend: young women arriving with severe complications after using MTP kits without medical supervision.

“When used unsupervised, these pills can lead to serious health risks. Such complications may not only require emergency surgical intervention but can also lead to long-term consequences like infertility or, in extreme cases, life-threatening blood loss. Especially if given in ectopic pregnancies without diagnosing, they can lead to life-threatening consequences and hence should never be taken without medical supervision and prescription.”

  • Ridhima Gupta
    ABOUT THE AUTHOR
    Ridhima Gupta

    Ridhima Gupta is a Principal Correspondent at Hindustan Times, where she covers healthcare, pharmaceuticals, and public health policy. Her reporting centers on Delhi’s major hospitals (AIIMS, Safdarjung, Lok Nayak), the state health department, and emerging medical trends. Ridhima is particularly interested in reporting on healthcare issues through the lens of women, children, and persons with disabilities. Her work often explores the intersection of healthcare and public policy, examining how these factors shape access health care. Based in New Delhi, many of her reports have led to direct government action over the years, in different city. Earlier this year, she completed a media training workshop on the Impact of Extreme Heat on Health, organised by the Global Strategic Communications Council (GSCC), further strengthening her interest in reporting on the intersection of climate change and public health. A postgraduate from the Asian College of Journalism, Chennai, Ridhima has around a decade of experience in journalism. She began her career as a trainee television reporter with Mirror Now in Mumbai and has since worked across multiple cities, including Bengaluru, Hyderabad, and Delhi, contributing to both print and broadcast newsrooms. She is a recipient of the Laadli Media Fellowship (2022) for her reporting on education, disability, and women’s issues. Before joining Hindustan Times, Ridhima worked with The Times of India, New Indian Express and News18. A native of Jhansi, Uttar Pradesh, Ridhima completed her undergraduate studies in Biotechnology. And when she is not working as a journalist she likes to paint and go on nature hikes.Read More

Catch every big hit, every wicket with Crickit, a one stop destination for Live Scores, Match Stats, Infographics & much more. Explore now!

Stay updated with all top Cities including, Bengaluru, Delhi, Mumbai and more across India. Stay informed on the latest happenings in World News along with Delhi Election 2025 and Delhi Election Result 2025 Live, New Delhi Election Result Live, Kalkaji Election Result Live at Hindustan Times.